For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anxiety | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCAE 3.0 | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Blood glucose increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Dry eye syndrome | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Laryngeal inflamation | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Laryngitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Leukopenia | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Lip pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Neurology (Other) - Drowsiness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCAE 3.0 | View |
| Bone pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Lymph node pain | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCAE 3.0 | View |
| Lymphatics (Other) - Left axillary nodule | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCAE 3.0 | View |
| Metabolic/Laboratory (Other) - Anemia | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Rash acneiform | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Allergic rhinitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Allergy/Immunology (Other) - Allergic Sinusitis | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Allergy/Immunology (Other) - Lidocaine | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Allergy/Immunology (Other) - Respiratory | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Bruising | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCAE 3.0 | View |
| Bruising - Injury / Laceration | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Conjunctival disorder | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Constitutional Symptoms (Other) - Pelvic Cystic Mass | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCAE 3.0 | View |
| Dermatology/Skin (Other) | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Dermatology/Skin (Other) - Injury / Laceration | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Dermatology/Skin (Other) - non-malignant growths | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Dermatology/Skin (Other) - Rash NOS | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Dermatology/Skin (Other) - Rash: Erithematous | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Dermatology/Skin (Other) - SCC | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Dermatology/Skin (Other)- non-malignant skin cancer | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCAE 3.0 | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Edema limbs | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Eye pain | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Eyelid function disorder - Eyelid edema | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Facial pain | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Gastrointestinal (Other) - Colorectal polyps | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Gastrointestinal (Other) - GERD | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Gingival infection | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Gingival pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Headache | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Hemoglobin decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Infection - COVID + | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCAE 3.0 | View |
| Infection - Human Rhinovirus | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCAE 3.0 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCAE 3.0 | View |
| Joint disorder | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Joint infection | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Metabolic/Laboratory (Other) - Hypercapnia | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Metabolic/Laboratory (Other) - Hyperglycemia | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Metabolic/Laboratory (Other) - Hypomagnesemia | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Metabolic/Laboratory (Other) - Hypophosphatemia | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Metabolic/Laboratory (Other) - Lymphocyte Abs increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Metabolic/Laboratory (Other) - Vitamin D defficiency | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Mucositis oral | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Musculoskeletal (Other) - Cramps | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Musculoskeletal (Other) - Injury | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Musculoskeletal (Other) - muscle aches | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Musculoskeletal (Other) - Pulled muscle | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Nail infection | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Nasal congestion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Night Sweats | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Ocular/Visual (Other) - Blurred Vision | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Ocular/Visual (Other) - Dysfunctional Tear Syndrome | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Ocular/Visual (Other) - Edema Lids | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Ocular/Visual (Other) - Increased Eye Pressure | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Ocular/Visual (Other) - Irritated Eyes | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Ocular/Visual (Other) - Ocular Conjunctive Hemmorhage | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Ocular/Visual (Other) - Watery eyes | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Oral pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Otitis media | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Pain (Other) | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Pain (Other) - L Thigh | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 3.0 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Pharyngolaryngeal pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Pulmonary (Other) - Chest Congestion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Rash desquamating | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Rhinitis infective | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Serum magnesium decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Serum phosphate decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 3.0 | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Skin and subcutaneous tissue disorders - Injury / Laceration | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Sweating | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Treatment related secondary malignancy (Specify, Other) - SCC | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Upper respiratory infection | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 3.0 | View |
| Vascular (Other) | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCAE 3.0 | View |
| Vision blurred | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 3.0 | View |
| Watering eyes | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 3.0 | View |
| Wound infection - Injury / Laceration | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 3.0 | View |
| Wound infection - Injury / Laceration / Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCAE 3.0 | View |